Hospital for Special Surgery - Archive Scleroderma and Vasculitis Center
Filter by year
2026
February
09,
2026
|
16:32 PM
America/New_York
Everyday Health featuring Lindsay S. Lally, MD
Read more
2025
December
02,
2025
|
12:22 PM
America/New_York
The New York Times featuring Jessica K. Gordon, MD
Read more
September
08,
2025
|
19:12 PM
America/New_York
Mogil's MobCast: A Scleroderma Chat featuring Jessica K. Gordon, MD
Read more
March
06,
2025
|
10:00 AM
America/New_York
Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often devastating autoimmune disease that causes fibrosis (tissue …
Read more
2024
November
18,
2024
|
10:30 AM
America/New_York
New research to be presented by an investigator from Hospital for Special Surgery (HSS) shows avacopan is effective in achieving disease control with less steroid exposure in patients with ear, nose and throat (ENT) manifestations of ANCA associated …
Read more
2023
2022
2021
June
05,
2021
|
17:36 PM
America/New_York
Healio Rheumatology featuring Robert F. Spiera, MD
Read more
April
15,
2021
|
07:01 AM
America/New_York
Scleroderma News featuring Kimberly Showalter, MDrn
Read more
January
15,
2021
|
21:30 PM
America/New_York
U.S. News & World Report featuring Lindsay S. Lally, MD
Read more
2020
June
15,
2020
|
10:29 AM
America/New_York
The Rheumatologist featuring Robert F. Spiera, MD
Read more
June
04,
2020
|
11:44 AM
America/New_York
Rheumatology News featuring Lindsay S. Lally, MD
Read more
2019
December
24,
2019
|
09:12 AM
America/New_York
CreakyJoints featuring Lindsay S. Lally, MD, and Robert F. Spiera, MD
Read more
March
20,
2019
|
08:00 AM
America/New_York
Hospital for Special Surgery is evaluating a novel therapeutic approach for diffuse cutaneous systemic sclerosis (dcSSc), one of the most serious, potentially disabling and life-threatening rheumatic diseases. The double-blind, randomized, …
Read more
2018
November
19,
2018
|
07:00 AM
America/New_York
Robert F. Spiera, MD, rheumatologist at HSS, is interviewed at the annual ACR conference by MedPage Today talking about the study that he presented on the safety and efficacy of lenabasum in diffuse scleroderma patients.He explains how his team saw …
Read more
January
10,
2018
|
07:00 AM
America/New_York
Scleroderma is a terribly debilitating disease with no effective treatments and the mortality rates are still upwards of 20%-50%, the highest of any rheumatic disease.This disabling autoimmune disorder results in inflammation and fibrosis leading to …
Read more
